Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema

NCT01363440 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

466

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321)
PROCEDURE: Macular Laser Photocoagulation

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]